glp 1 side effects blindness Unexpected GLP-1 Effects: Do They Cause Vision Problems Common in Diabetes? Doctor Explains GLP 1 Blindness

Bypasses upstream endocrine stimulation: Unlike peptides that stimulate growth hormone release, IGF-1 LR3 does not depend on pituitary activation

While formal pharmacokinetic parameters (Cmax, AUC, t1/2) have not been published in peer-reviewed literature for oral dosing in humans, its low molecular weight (173 Da), positive charge, and water solubility support intestinal absorption

Suppressing glucagon secretion: this helps prevent unnecessary glucose release by the liver

Findings from the ATTAIN Phase III clinical trial programme investigating orforglipron as a tool for weight management will be shared later in 2025